Currently, NE differentiation in breast cancers has been assessed by immunohistochemical procedures detecting “general” NE markers such as chromogranin A (CHGA) and synaptophysin (SYP), and elucidation of specific hormonal peptides has been absent or unproductive [6]. The gene discussed is CHGA; the disease is breast carcinoma.